*Futures & Options educational trades for the week 8.11.21 to 12.11.21*
(My trade guidelines -appended below - apply).
#stockmarket
*FUTURES*
*SUNPHARMA* cmp 799.45 buy upto 777.00 stop 770.00 target 850.00+
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
- Home
- SUNPHARMA Forum
SUNPHARMA
858.7 -1.05 (-0.12%)
Updated 01:19 17/01 IST
93% Bullish
7% Bearish
42 Users have submitted 43 trade ideas of Rs. 5,422,725.1 for SUNPHARMA
DisclaimerBrokerage Reports
No. of reports in last year
13
No. of analysts
6
Average Consensus Forecast
850.31
Consensus Potential
-3.87%
SUNPHARMA Share Price Discussion
Add your reply here
N
Reputation: 21,444 • Nov 7, 2021 4:36 AM
Sun Pharma, Lupin recall products in US market
According to USFDA, the Mumbai-based drug maker is recalling the affected lot due to "failed moisture limits."
According to USFDA, the Mumbai-based drug maker is recalling the affected lot due to "failed moisture limits."
The Economic Times
Like
Add your reply here
R
Reputation: 21,647 • Nov 6, 2021 1:30 AM
Motilal Oswal target on SUNPHARMA
Date: 03-Nov-21
Broker: Motilal Oswal
Price @ Call: 815
Target: 970
Potential: 19.02%
Recommendation: BUY
Like
Add your reply here
H
Reputation: 956 • Nov 5, 2021 9:49 AM
*Sun Pharmaceuticals – Q2FY22 R U (BUY)*
CMP: Rs 815 (Upside 14%) MCap: Rs 1,956bn
*Sustained Q2, specialty traction continues*
Stellar Q2 driven by higher domestic growth (Covid 2% of India sales) and specialty sales ($155mn).
$10mn milestone payment from US specialty sales,...
Read more...
Like
Add your reply here
H
Reputation: 956 • Nov 5, 2021 9:45 AM
*Sun Pharma – Q2FY22 Concall Update – Nirmal Bang Sec.*
*Outlook – Positive*
The stock is trading at 24.7x FY23E consensus earnings
• All businesses have grown yoy except API
• Global Specialty – Rev $157 mn including $10mn milestone rev QoQ $148mn
• Ilumya has grown on both yoy...
Read more...
Like
Add your reply here
Add your reply here
R
Reputation: 21,647 • Nov 4, 2021 6:30 AM
HDFC Securities target on SUNPHARMA
Date: 03-Nov-21
Broker: HDFC Securities
Price @ Call: 815
Target: 990
Potential: 21.47%
Recommendation: BUY
2
Time frame?
Add your reply here
N
Reputation: 21,444 • Nov 4, 2021 3:21 AM
Most analysts raise target prices on Sun Pharma after strong Q2
CLSA, which raised the target price on Sun Pharma the most, said the drug maker's results were above estimates with key geographies performing well. Sun Pharma shares ended down 3.3% at ₹788 on Wednesday.
CLSA, which raised the target price on Sun Pharma the most, said the drug maker's results were above estimates with key geographies performing well. Sun Pharma shares ended down 3.3% at ₹788 on Wednesday.
The Economic Times
Like
Add your reply here
R
Reputation: 21,647 • Nov 3, 2021 1:30 AM
Nirmal Bang target on SUNPHARMA
Date: 03-Nov-21
Broker: Nirmal Bang
Price @ Call: 815
Target: 939
Potential: 15.21%
Recommendation: BUY
4
Add your reply here
R
Reputation: 21,647 • Nov 3, 2021 11:30 AM
Prabhudas Lilladher target on SUNPHARMA
Date: 03-Nov-21
Broker: Prabhudas Lilladher
Price @ Call: 815
Target: 1000
Potential: 22.7%
Recommendation: BUY
2
Add your reply here
Add your reply here
Add your reply here
N
Reputation: 21,444 • Nov 3, 2021 8:31 AM
Sun Pharma CFO on what led to the growth in Indian and US businesses
“Sun Pharma expects to gain momentum and continue to focus on building the prescriptions for core specialty products.”
“Sun Pharma expects to gain momentum and continue to focus on building the prescriptions for core specialty products.”
The Economic Times
1
Add your reply here
Add your reply here
Add your reply here
Add your reply here
Add your reply here
Add your reply here
Add your reply here
Add your reply here
SUNPHARMA Ratings
Long term SUNPHARMA rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
3.4/5 (12 Ratings)
Find answers to all your questions on live SUNPHARMA message board: Is SUNPHARMA buy or sell? Should I buy SUNPHARMA shares? Why are SUNPHARMA shares falling? Should I invest in SUNPHARMA stock?
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.